Heart failure with preserved ejection fraction (HF-PEF) accounts for more than 50% of heart failure cases. To date, medical therapy has failed to show improvements in diastolic dysfunction, cardiac remodelling, or cardiovascular outcomes. As mineralocorticoid receptor activation by aldosterone contributes to the pathophysiology of HF through several different mechanisms, the Aldosterone Receptor Blockade in Diastolic […]
Tag: diastolic dysfunction
Natural history of diastolic heart failure
Heart failure may develop with either reduced or preserved left ventricular ejection fraction (LVEF), with each form accounting for approximately half of cases. However, time-dependent changes in diastolic function have not been well investigated, and their relationship to clinical heart failure is not well understood. […]
Diastolic dysfunction leads to decreased exercise capacity
Determining the most important parameters affecting exercise performance, particularly in relation to age, could have important implications for rehabilitation. Although a reduction in maximal heart rate is known to be important, previous studies have implied that left ventricular systolic function did not correlate with maximal exercise time. […]